CClinicalTrials.gg
CompletedNCT03872466GRASPUpdated Mar 25, 2025Results posted

Glove Rehabilitation Application for Stroke Patients

An interventional study of GRASP HEP and Usual Care Treatment (UCT) in Occupational Therapy and Virtual Reality, sponsored by Barron Associates, Inc.. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-03-25.

Sponsored by Barron Associates, Inc. · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
21
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The University of Virginia (UVA) Director of Neurorehabilitation will lead GRASP randomized, controlled efficacy trials. The study will involve employment of the GRASP system in three one-hour sessions per week over eight weeks by stroke survivors suffering from ongoing hand function impairment.

Read the detailed description

Testing will involve employment of the GRASP system (glove orthosis, sensor package, and application software) in three one-hour sessions per week over eight weeks by stroke survivors suffering from ongoing hand function impairment. This frequency and duration is consistent with previous studies successfully investigating new upper extremity (UE) therapies. The primary outcome of the efficacy study will be change in hand function for a group of participants using the GRASP system versus a control group receiving standard care over the same period.

Participants assigned to the GRASP intervention group will attend five outpatient clinic visits for consent, pre-assessment, and familiarization with the system, followed by an initial home visit and eight weeks (3x per week) of independent at-home practice. In this study period, GRASP intervention group participants will employ the instrumented glove orthosis while performing functional tasks within virtual activities of daily living (ADLs).

Participants in the Usual Care Treatment (UCT) control group will continue to receive any previously prescribed therapy services. These patients will not receive any treatment services through the study as UCT control group participants.

02

Conditions studied

  • Occupational Therapy
  • Virtual Reality
03

In context

Lead sponsor

Barron Associates, Inc. is the lead sponsor of 10 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Participant has had a right or left hemispheric stroke affecting normal hand function;
  2. Participant has sufficient active finger flexion at the MCP joint in at least one finger to be detected by visual observation by a study therapist;
  3. Participant has visual acuity with corrective lenses of 20/50 or better;
  4. Participant's affected hand fits within sizing available for the glove orthosis;
  5. Participant is no longer in an active UE rehabilitation program; and
  6. Participant is currently living at a private residence and anticipates remaining at that location for the duration of study participation.

Exclusion criteria

Exclusion Criteria:

  1. Withholding or withdrawal of consent by the participant;
  2. Inability to understand and follow verbal directions;
  3. Determination by the Principal Investigator that participation would result in overexertion or significant discomfort or pain;

(3) A psychological diagnosis that in the determination of the Principal Investigator could significantly impact subject's participation or that could be aggravated by study participation (Principal Investigator will consult with candidate's personal physician as appropriate); (4) Determination by the Principal Investigator that participation would result in significant agitation or elevated stress; (5) Visual field deficit in either eye that impairs the ability to view the computer monitor; (6) Stiffness or contractures of the muscles, joints, tendons, ligaments, or skin that restricts normal movement; (7) More than mild tone/spasticity (measured on modified Ashworth, 5-point scale); (8) Severe contractures or joint deformities in the fingers; (9) Open wound or infection, severe edema, or excessive swelling which might interfere with wearing the glove; (10) Severe pre-stroke co-morbidities, such as cardiovascular, neurological, orthopedic, or rheumatoid impairments before stroke that may interfere with task performance; (11) Severe sensory deficits from the involved UE; or (12) Hemispatial neglect that impairs the ability to process and perceive visual stimuli provided through the computer monitor.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
21 participants (actual)

Study arms

  • Experimental
    GRASP Intervention

    This arm will perform eight weeks of independent home practice for upper extremity therapy using the GRASP system.

    Device: GRASP HEP

  • Active comparator
    Control

    Participants in the control group will continue to receive any previously prescribed therapy services. These patients will not receive any treatment services through the study as control group participants.

    Behavioral: Usual Care Treatment (UCT)

Interventions

  • DeviceGRASP HEP

    The GRASP system comprises a sensor package and therapy game software that works with a commercial glove orthosis to enable virtual world-based practice of activities of daily living (ADLs) involving the hand.

  • BehavioralUsual Care Treatment (UCT)

    Participants in the control group will continue to receive any previously prescribed therapy services. These patients will not receive any treatment services through the study as UCT group participants.

06

What researchers measure

Primary outcomes

  1. Pre Intervention Fugl-Meyer Assessment of Upper Extremity Motor Function (FMUE)

    FMUE is one of the most widely used and accepted quantitative measures of motor function in stroke patients, used in clinical and research settings. Individual patient movements associated with specific motor functions are scored using a 3-point ordinal scale (0, 1, or 2). The study employs a subscale of the full assessment that incorporates 33 items relevant to shoulder, elbow, forearm, wrist, hand, and grasp function, thus creating a possible range of 0 to 66 points. Higher scores correspond to higher levels of motor function.

    Time frame: Pre-intervention at Baseline

  2. Post Intervention Fugl-Meyer Assessment of Upper Extremity Motor Function (FMUE)

    FMUE is one of the most widely used and accepted quantitative measures of motor function in stroke patients, used in clinical and research settings. Individual patient movements associated with specific motor functions are scored using a 3-point ordinal scale (0, 1, or 2). The study employs a subscale of the full assessment that incorporates 33 items relevant to shoulder, elbow, forearm, wrist, hand, and grasp function, thus creating a possible range of 0 to 66 points. Higher scores correspond to higher levels of motor function.

    Time frame: Post Intervention at 8 weeks

Secondary outcomes

  1. Pre Intervention Wolf Motor Function Test Functional Assessment (WMFT-FA)

    The WMFT test is a functionally-oriented clinical and research instrument. The test consists of 15 motor tasks scored both for time and quality of movement. The WMFT Functional Assessment (WMFT-FA) score is an observational assessment of movement quality and scored using a 6-point ordinal rating scale that ranges from 0 (no use of the affected side attempted) to 5 (normal function). A total WMFT-FA score is calculated by taking the average across all 15 UE tasks. A patient's WMFT-FA score is thus a real number that can range from 0 to 5. An increase in WMFT-FA score implies improved motor function.

    Time frame: Pre-intervention at Baseline

  2. Post Intervention Wolf Motor Function Test Functional Assessment (WMFT-FA)

    The WMFT test is a functionally-oriented clinical and research instrument. The test consists of 15 motor tasks scored both for time and quality of movement. The WMFT Functional Assessment (WMFT-FA) score is an observational assessment of movement quality and scored using a 6-point ordinal rating scale that ranges from 0 (no use of the affected side attempted) to 5 (normal function). A total WMFT-FA score is calculated by taking the average across all 15 UE tasks. A patient's WMFT-FA score is thus a real number that can range from 0 to 5. An increase in WMFT-FA score implies improved motor function.

    Time frame: Post Intervention at 8 weeks

  3. Pre Intervention Wolf Motor Function Test Time (WMFT-TIME)

    The WMFT test is a functionally-oriented clinical and research instrument. The test consists of 15 motor tasks scored both for time and quality of movement. WMFT-TIME is a quantitative measure calculated using the average time to complete the tasks. Any time greater than 120 seconds is recorded as 120 seconds. A patient's WMFT-TIME score (average completion time) thus ranges from 0 to 120. A reduction in WMFT-TIME implies improved motor function.

    Time frame: Pre-intervention at Baseline

  4. Post Intervention Wolf Motor Function Test Time (WMFT-TIME)

    The WMFT test is a functionally-oriented clinical and research instrument. The test consists of 15 motor tasks scored both for time and quality of movement. WMFT-TIME is a quantitative measure calculated using the average time to complete the tasks. Any time greater than 120 seconds is recorded as 120 seconds. A patient's WMFT-TIME score (average completion time) thus ranges from 0 to 120. A reduction in WMFT-TIME implies improved motor function.

    Time frame: Post Intervention at 8 weeks

  5. Pre Intervention Box and Blocks Test (BBT)

    The BBT provides a measure of unilateral gross manual dexterity. Subjects are asked to move 2.5 cm wooden cubes from one 8.5 cm tall box to another, as quickly as possible. The BBT score is simply the number of blocks moved in 60 seconds. A patient's WMFT-FA score is thus an integer number if blocks that is greater than or equal to zero. The maximum number of blocks is 150. An increase in BBT score implies improved motor function.

    Time frame: Pre-intervention at Baseline

  6. Post Intervention Box and Blocks Test (BBT)

    The BBT provides a measure of unilateral gross manual dexterity. Subjects are asked to move 2.5 cm wooden cubes from one 8.5 cm tall box to another, as quickly as possible. The BBT score is simply the number of blocks moved in 60 seconds. A patient's WMFT-FA score is thus an integer number if blocks that is greater than or equal to zero. The maximum number of blocks is 150. An increase in BBT score implies improved motor function.

    Time frame: Post Intervention at 8 weeks

  7. Pre Intervention Motor Activity Log - Amount (MAL-Amount)

    The MAL is a structured interview assessing use of the affected arm in 30 daily activities in the subject's real-life experience. These range from turning on a light to eating finger foods. For each activity, the subject provides a self-assessment of the frequency with which the affected arm is involved in the activity (MAL-Amount) and the quality with which the affected arm performs (MAL-How Well). Grading is on a Likert scale. At the low end, 0 corresponds to never using the weaker arm for the activity. On the upper end, 5 corresponds to using the weaker arm equivalently to the stronger arm. A total MAL-Amount score is calculated by taking the average across all 30 activities. Likewise, a total MAL-How Well score is calculated by taking the average across all 30 activities. A patient's MAL-Amount and MAL-How Well scores are thus real numbers that can range from 0 to 5. An increase in these scores implies improved motor function.

    Time frame: Pre-intervention at Baseline

  8. Post Intervention Motor Activity Log - Amount (MAL-Amount)

    The MAL is a structured interview assessing use of the affected arm in 30 daily activities in the subject's real-life experience. These range from turning on a light to eating finger foods. For each activity, the subject provides a self-assessment of the frequency with which the affected arm is involved in the activity (MAL-Amount) and the quality with which the affected arm performs (MAL-How Well). Grading is on a Likert scale. At the low end, 0 corresponds to never using the weaker arm for the activity. On the upper end, 5 corresponds to using the weaker arm equivalently to the stronger arm. A total MAL-Amount score is calculated by taking the average across all 30 activities. Likewise, a total MAL-How Well score is calculated by taking the average across all 30 activities. A patient's MAL-Amount and MAL-How Well scores are thus real numbers that can range from 0 to 5. An increase in these scores implies improved motor function.

    Time frame: Post Intervention at 8 weeks

  9. Pre Intervention Motor Activity Log - How Well (MAL-How Well)

    The MAL is a structured interview assessing use of the affected arm in 30 daily activities in the subject's real-life experience. These range from turning on a light to eating finger foods. For each activity, the subject provides a self-assessment of the frequency with which the affected arm is involved in the activity (MAL-Amount) and the quality with which the affected arm performs (MAL-How Well). Grading is on a Likert scale. At the low end, 0 corresponds to never using the weaker arm for the activity. On the upper end, 5 corresponds to using the weaker arm equivalently to the stronger arm. A total MAL-Amount score is calculated by taking the average across all 30 activities. Likewise, a total MAL-How Well score is calculated by taking the average across all 30 activities. A patient's MAL-Amount and MAL-How Well scores are thus real numbers that can range from 0 to 5. An increase in these scores implies improved motor function.

    Time frame: Pre-intervention at Baseline

  10. Post Intervention Motor Activity Log - How Well (MAL-How Well)

    The MAL is a structured interview assessing use of the affected arm in 30 daily activities in the subject's real-life experience. These range from turning on a light to eating finger foods. For each activity, the subject provides a self-assessment of the frequency with which the affected arm is involved in the activity (MAL-Amount) and the quality with which the affected arm performs (MAL-How Well). Grading is on a Likert scale. At the low end, 0 corresponds to never using the weaker arm for the activity. On the upper end, 5 corresponds to using the weaker arm equivalently to the stronger arm. A total MAL-Amount score is calculated by taking the average across all 30 activities. Likewise, a total MAL-How Well score is calculated by taking the average across all 30 activities. A patient's MAL-Amount and MAL-How Well scores are thus real numbers that can range from 0 to 5. An increase in these scores implies improved motor function.

    Time frame: Post Intervention at 8 weeks

07

Results

Posted Mar 25, 2025

Participant flow

Participant flow — Overall Study
MilestoneGRASP InterventionControl
Started129
Completed99
Not completed30
Withdrew: Withdrawal by subject10
Withdrew: Physician decision20

Outcome measures

PrimaryPre Intervention Fugl-Meyer Assessment of Upper Extremity Motor Function (FMUE)

FMUE is one of the most widely used and accepted quantitative measures of motor function in stroke patients, used in clinical and research settings. Individual patient movements associated with specific motor functions are scored using a 3-point ordinal scale (0, 1, or 2). The study employs a subscale of the full assessment that incorporates 33 items relevant to shoulder, elbow, forearm, wrist, hand, and grasp function, thus creating a possible range of 0 to 66 points. Higher scores correspond to higher levels of motor function.

Time frame:
Pre-intervention at Baseline
Reported as:
Mean · score on a scale
Pre Intervention Fugl-Meyer Assessment of Upper Extremity Motor Function (FMUE)
score on a scaleGRASP InterventionControl
Pre Intervention Fugl-Meyer Assessment of Upper Extremity Motor Function (FMUE)42.22 (35.66 to 48.78)42.44 (35.89 to 49.00)
PrimaryPost Intervention Fugl-Meyer Assessment of Upper Extremity Motor Function (FMUE)

FMUE is one of the most widely used and accepted quantitative measures of motor function in stroke patients, used in clinical and research settings. Individual patient movements associated with specific motor functions are scored using a 3-point ordinal scale (0, 1, or 2). The study employs a subscale of the full assessment that incorporates 33 items relevant to shoulder, elbow, forearm, wrist, hand, and grasp function, thus creating a possible range of 0 to 66 points. Higher scores correspond to higher levels of motor function.

Time frame:
Post Intervention at 8 weeks
Reported as:
Mean · score on a scale
Post Intervention Fugl-Meyer Assessment of Upper Extremity Motor Function (FMUE)
score on a scaleGRASP InterventionControl
Post Intervention Fugl-Meyer Assessment of Upper Extremity Motor Function (FMUE)52.33 (45.77 to 58.89)44.00 (37.44 to 50.56)
SecondaryPre Intervention Wolf Motor Function Test Functional Assessment (WMFT-FA)

The WMFT test is a functionally-oriented clinical and research instrument. The test consists of 15 motor tasks scored both for time and quality of movement. The WMFT Functional Assessment (WMFT-FA) score is an observational assessment of movement quality and scored using a 6-point ordinal rating scale that ranges from 0 (no use of the affected side attempted) to 5 (normal function). A total WMFT-FA score is calculated by taking the average across all 15 UE tasks. A patient's WMFT-FA score is thus a real number that can range from 0 to 5. An increase in WMFT-FA score implies improved motor function.

Time frame:
Pre-intervention at Baseline
Reported as:
Mean · score on a scale
Pre Intervention Wolf Motor Function Test Functional Assessment (WMFT-FA)
score on a scaleGRASP InterventionControl
Pre Intervention Wolf Motor Function Test Functional Assessment (WMFT-FA)2.70 (2.20 to 3.19)2.67 (2.17 to 3.16)
SecondaryPost Intervention Wolf Motor Function Test Functional Assessment (WMFT-FA)

The WMFT test is a functionally-oriented clinical and research instrument. The test consists of 15 motor tasks scored both for time and quality of movement. The WMFT Functional Assessment (WMFT-FA) score is an observational assessment of movement quality and scored using a 6-point ordinal rating scale that ranges from 0 (no use of the affected side attempted) to 5 (normal function). A total WMFT-FA score is calculated by taking the average across all 15 UE tasks. A patient's WMFT-FA score is thus a real number that can range from 0 to 5. An increase in WMFT-FA score implies improved motor function.

Time frame:
Post Intervention at 8 weeks
Reported as:
Mean · score on a scale
Post Intervention Wolf Motor Function Test Functional Assessment (WMFT-FA)
score on a scaleGRASP InterventionControl
Post Intervention Wolf Motor Function Test Functional Assessment (WMFT-FA)3.42 (2.73 to 4.12)2.84 (2.14 to 3.53)
SecondaryPre Intervention Wolf Motor Function Test Time (WMFT-TIME)

The WMFT test is a functionally-oriented clinical and research instrument. The test consists of 15 motor tasks scored both for time and quality of movement. WMFT-TIME is a quantitative measure calculated using the average time to complete the tasks. Any time greater than 120 seconds is recorded as 120 seconds. A patient's WMFT-TIME score (average completion time) thus ranges from 0 to 120. A reduction in WMFT-TIME implies improved motor function.

Time frame:
Pre-intervention at Baseline
Reported as:
Mean · score on a scale
Pre Intervention Wolf Motor Function Test Time (WMFT-TIME)
score on a scaleGRASP InterventionControl
Pre Intervention Wolf Motor Function Test Time (WMFT-TIME)8.52 (4.49 to 16.17)11.01 (5.80 to 20.90)
SecondaryPost Intervention Wolf Motor Function Test Time (WMFT-TIME)

The WMFT test is a functionally-oriented clinical and research instrument. The test consists of 15 motor tasks scored both for time and quality of movement. WMFT-TIME is a quantitative measure calculated using the average time to complete the tasks. Any time greater than 120 seconds is recorded as 120 seconds. A patient's WMFT-TIME score (average completion time) thus ranges from 0 to 120. A reduction in WMFT-TIME implies improved motor function.

Time frame:
Post Intervention at 8 weeks
Reported as:
Mean · score on a scale
Post Intervention Wolf Motor Function Test Time (WMFT-TIME)
score on a scaleGRASP InterventionControl
Post Intervention Wolf Motor Function Test Time (WMFT-TIME)6.97 (3.67 to 13.24)7.46 (3.93 to 14.16)
SecondaryPre Intervention Box and Blocks Test (BBT)

The BBT provides a measure of unilateral gross manual dexterity. Subjects are asked to move 2.5 cm wooden cubes from one 8.5 cm tall box to another, as quickly as possible. The BBT score is simply the number of blocks moved in 60 seconds. A patient's WMFT-FA score is thus an integer number if blocks that is greater than or equal to zero. The maximum number of blocks is 150. An increase in BBT score implies improved motor function.

Time frame:
Pre-intervention at Baseline
Reported as:
Mean · blocks
Pre Intervention Box and Blocks Test (BBT)
blocksGRASP InterventionControl
Pre Intervention Box and Blocks Test (BBT)22.89 (15.29 to 34.26)12.78 (6.48 to 25.19)
SecondaryPost Intervention Box and Blocks Test (BBT)

The BBT provides a measure of unilateral gross manual dexterity. Subjects are asked to move 2.5 cm wooden cubes from one 8.5 cm tall box to another, as quickly as possible. The BBT score is simply the number of blocks moved in 60 seconds. A patient's WMFT-FA score is thus an integer number if blocks that is greater than or equal to zero. The maximum number of blocks is 150. An increase in BBT score implies improved motor function.

Time frame:
Post Intervention at 8 weeks
Reported as:
Mean · blocks
Post Intervention Box and Blocks Test (BBT)
blocksGRASP InterventionControl
Post Intervention Box and Blocks Test (BBT)28.44 (20.85 to 38.81)14.44 (7.76 to 26.88)
SecondaryPre Intervention Motor Activity Log - Amount (MAL-Amount)

The MAL is a structured interview assessing use of the affected arm in 30 daily activities in the subject's real-life experience. These range from turning on a light to eating finger foods. For each activity, the subject provides a self-assessment of the frequency with which the affected arm is involved in the activity (MAL-Amount) and the quality with which the affected arm performs (MAL-How Well). Grading is on a Likert scale. At the low end, 0 corresponds to never using the weaker arm for the activity. On the upper end, 5 corresponds to using the weaker arm equivalently to the stronger arm. A total MAL-Amount score is calculated by taking the average across all 30 activities. Likewise, a total MAL-How Well score is calculated by taking the average across all 30 activities. A patient's MAL-Amount and MAL-How Well scores are thus real numbers that can range from 0 to 5. An increase in these scores implies improved motor function.

Time frame:
Pre-intervention at Baseline
Reported as:
Mean · score on a scale
Pre Intervention Motor Activity Log - Amount (MAL-Amount)
score on a scaleGRASP InterventionControl
Pre Intervention Motor Activity Log - Amount (MAL-Amount)1.33 (0.80 to 1.86)1.30 (0.77 to 1.83)
SecondaryPost Intervention Motor Activity Log - Amount (MAL-Amount)

The MAL is a structured interview assessing use of the affected arm in 30 daily activities in the subject's real-life experience. These range from turning on a light to eating finger foods. For each activity, the subject provides a self-assessment of the frequency with which the affected arm is involved in the activity (MAL-Amount) and the quality with which the affected arm performs (MAL-How Well). Grading is on a Likert scale. At the low end, 0 corresponds to never using the weaker arm for the activity. On the upper end, 5 corresponds to using the weaker arm equivalently to the stronger arm. A total MAL-Amount score is calculated by taking the average across all 30 activities. Likewise, a total MAL-How Well score is calculated by taking the average across all 30 activities. A patient's MAL-Amount and MAL-How Well scores are thus real numbers that can range from 0 to 5. An increase in these scores implies improved motor function.

Time frame:
Post Intervention at 8 weeks
Reported as:
Mean · score on a scale
Post Intervention Motor Activity Log - Amount (MAL-Amount)
score on a scaleGRASP InterventionControl
Post Intervention Motor Activity Log - Amount (MAL-Amount)2.55 (1.84 to 3.25)1.18 (0.48 to 1.89)
SecondaryPre Intervention Motor Activity Log - How Well (MAL-How Well)

The MAL is a structured interview assessing use of the affected arm in 30 daily activities in the subject's real-life experience. These range from turning on a light to eating finger foods. For each activity, the subject provides a self-assessment of the frequency with which the affected arm is involved in the activity (MAL-Amount) and the quality with which the affected arm performs (MAL-How Well). Grading is on a Likert scale. At the low end, 0 corresponds to never using the weaker arm for the activity. On the upper end, 5 corresponds to using the weaker arm equivalently to the stronger arm. A total MAL-Amount score is calculated by taking the average across all 30 activities. Likewise, a total MAL-How Well score is calculated by taking the average across all 30 activities. A patient's MAL-Amount and MAL-How Well scores are thus real numbers that can range from 0 to 5. An increase in these scores implies improved motor function.

Time frame:
Pre-intervention at Baseline
Reported as:
Mean · score on a scale
Pre Intervention Motor Activity Log - How Well (MAL-How Well)
score on a scaleGRASP InterventionControl
Pre Intervention Motor Activity Log - How Well (MAL-How Well)1.35 (0.79 to 1.91)1.18 (0.62 to 1.74)
SecondaryPost Intervention Motor Activity Log - How Well (MAL-How Well)

The MAL is a structured interview assessing use of the affected arm in 30 daily activities in the subject's real-life experience. These range from turning on a light to eating finger foods. For each activity, the subject provides a self-assessment of the frequency with which the affected arm is involved in the activity (MAL-Amount) and the quality with which the affected arm performs (MAL-How Well). Grading is on a Likert scale. At the low end, 0 corresponds to never using the weaker arm for the activity. On the upper end, 5 corresponds to using the weaker arm equivalently to the stronger arm. A total MAL-Amount score is calculated by taking the average across all 30 activities. Likewise, a total MAL-How Well score is calculated by taking the average across all 30 activities. A patient's MAL-Amount and MAL-How Well scores are thus real numbers that can range from 0 to 5. An increase in these scores implies improved motor function.

Time frame:
Post Intervention at 8 weeks
Reported as:
Mean · score on a scale
Post Intervention Motor Activity Log - How Well (MAL-How Well)
score on a scaleGRASP InterventionControl
Post Intervention Motor Activity Log - How Well (MAL-How Well)2.70 (2.06 to 3.34)1.20 (0.56 to 1.84)

Adverse events

Collected over 8 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
GRASP Intervention0/12 (0%)0/12 (0%)0/12 (0%)
Control0/9 (0%)0/9 (0%)0/9 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)GRASP InterventionControlTotal
Median62 (45 to 82)60 (34 to 86)60 (34 to 86)
Sex: Female, Male
Sex: Female, Male(Participants)GRASP InterventionControlTotal
Female639
Male6612
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)GRASP InterventionControlTotal
Hispanic or Latino000
Not Hispanic or Latino12921
Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)GRASP InterventionControlTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American303
White9817
More than one race000
Unknown or Not Reported011
Region of Enrollment
Region of Enrollment(participants)GRASP InterventionControlTotal
United States12921
08

Study locations

1 site
  • UVA Outpatient Rehabilitation Clinic
    Charlottesville, Virginia 22901, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Sep 18, 2020

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 25, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03872466
Lead sponsor
Barron Associates, Inc.
Collaborators
University of Virginia
Responsible party
Sponsor
First posted
Mar 13, 2019
Start date
Jun 11, 2020
Primary completion
Apr 26, 2022
Completion
Apr 26, 2022
Results posted
Mar 25, 2025
Last update
Mar 25, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion